latest blog entries
Loading...
Branding...
latest headlines for company on cafepharma
Motley Fool
Sat, 05/18/13 - 11:54 am
Motley Fool
Sun, 04/28/13 - 12:13 pm
tags: Achillion, Avanir, Gilead Sciences, GSK, Medivation, Pfizer, Theravance
Bloomberg
Sun, 04/28/13 - 12:04 pm
Motley Fool
Sun, 04/07/13 - 10:42 am
Motley Fool
Sun, 02/24/13 - 3:20 pm
Yahoo/BusinessWire
Sat, 02/16/13 - 12:33 pm
Reuters
Tue, 01/15/13 - 12:37 pm
Motley Fool
Sun, 12/30/12 - 1:15 pm
tags: Abbott Laboratories, Achillion, Gilead Sciences, GSK, HCV, hepatitis C, Idenix, JNJ, Merck, Vertex Pharmaceuticals
Investopedia
Sat, 12/29/12 - 10:42 am
Motley Fool
Wed, 12/26/12 - 10:30 am
tags: Adasuve, Alexza, Cangene, drug approvals, FDA, Gattex, Gilead Sciences, NPS Pharmaceuticals, Roche, Tamiflu, VariZIG
Motley Fool
Sat, 12/15/12 - 2:28 pm
tags: Affymax, Alzheimer's disease, Amyvid, anemia, Arena Pharmaceuticals, Belviq, Bosulif, chronic myeloid leukemia, Eli Lilly, Eylea, Gilead Sciences, HIV, Ironwood Pharmaceuticals, irritable bowel syndrome, Kyprolis, Linzess, macular degeneration, Medivation, Multiple Myeloma, obesity, Omontys, ONYX Pharmaceuticals, Pfizer, prostate cancer, Qsymia, Regeneron, Stribild, Vivus, weight loss, Xtandi
Last 30 twitter posts
-
Gilead Sciences' Management Presents at the 2013 UBS Global Healthcare Conference (Transcript) t.co/SKdV9oRhAJ
-
Gilead Sciences' Management Presents at the 2013 UBS Global Healthcare Conference (Transcript) t.co/QCdod375KT #biotech
-
RT @RandDDirections: Gilead Sciences Reports Good Phase II Data for Leukemia Drug t.co/ZQwu4no2LX #Pharmalive
-
Gilead Sciences selecciona key account manager en #Madrid #Empleo t.co/CLHzm66fO6
-
RT @matthew36pl: May 2 (Reuters) - Gilead Sciences Inc on Thursday said almost all patients taking a fixed-dose combination of two of its experimental hep..
-
Too expensive for now II, but...Gilead Sciences (GILD), Ecolab (ECL), Home Depot (HD), Raytheon (RTN), Schlumberger (SLB), Southern Co. (SO)
-
Jim Cramer: Buy Gilead Sciences, Kinder Morgan, and These 3 … t.co/2ovFKKVgSh #JimCramer
-
RT @super_trades: $EAC Cramer ranked it a buy t.co/xC8FnYr9MS
-
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday May 20 t.co/UfOsxfdz8b
-
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday May 20 t.co/pz8I75f9ch
-
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20 t.co/al3nrirUK3
-
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on ... - Investor's Business Daily : t.co/JH7uRWVpL8
-
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20: [Business Wire] - G... t.co/n9gwbdBh0F
-
GILEAD SCIENCES, INC. : Gilead Sciences to Present at the 2013 UBS Global ... - 4-traders (press release) : t.co/srzwPqwuwj
-
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20 t.co/Qp2JS0jvki
-
Gilead Sciences (GILD +2.4%) finishes higher today after UBS raised its price target to $67 from $63 ... t.co/yPtUNOf6R0 $GILD
-
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20 t.co/GpUp0edfLa
-
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20 t.co/sv0HBRVfLt
-
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20 t.co/h0sVqIt3cb
-
Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20 t.co/dRG1GLTjsF #biotech
-
Gilead Sciences Reports Good Phase II Data for Leukemia Drug t.co/nq44XTJXQt #Pharmalive
-
Gilead Sciences Reports Good Phase II Data for Leukemia Drug t.co/ZQwu4no2LX #Pharmalive
-
RT @super_trades: $EAC Cramer ranked it a buy t.co/xC8FnYr9MS
-
RT @LaurenScolardi: $EAC Cramer ranked it a buy t.co/uuk4yku3ul
-
$EAC Cramer ranked it a buy t.co/uuk4yku3ul
-
RT @super_trades: $EAC Cramer ranked it a buy t.co/xC8FnYr9MS
-
RT @super_trades: $EAC Cramer ranked it a buy t.co/xC8FnYr9MS
-
$EAC Cramer ranked it a buy t.co/xC8FnYr9MS
-
@super_trades Cramer rates $EAC as BUY t.co/KM9ujPbkcE $EAC $EPD $FRT $GILD $KMP
-
Jim Cramer: Buy Gilead Sciences, Kinder Morgan, and These 3 Solid Stocks Now t.co/zzY5GDyAd6
Latest Health Message Board Posts
Are they all oral for genotype 1? Nope FOSTER CITY, Calif.--(BUSINESS WIRE)--Apr. 8, 2013-- Gilead Sciences (Nasdaq: GILD) today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ...
Posted by:
ActingBrandNew
at
2013-05-09 05:00:00
on
medhelp.org
... SERUM LEVELS OF IFN-? Move back Print add this item to your Itinerary S. Pflanz*, A. Fosdick, T. Cihlar, M. Subramanian Gilead Sciences, Foster City, CA, USA. *stefan.***@**** Background and aims: The selective oral TLR7 agonist GS-9620 is being developed ...
Posted by:
grateful_to_be_here
at
2013-05-04 05:00:00
on
medhelp.org
... . Although my wk8 results (got 'em yesterday at my wk10 vein stabbing) are still "undetectable", I was also informed that Gilead Sciences reverted the 12wk-no-Riba-changed-to-24wks arm back to 12 weeks. So, like you, since I did not achieve undetectable ...
Posted by:
HectorSF
at
2013-05-04 05:00:00
on
medhelp.org
... containing simeprevir (formerly TMC435), a NS3/4A protease inhibitor being jointly developed by Janssen and Medivir AB, plus Gilead Sciences' NS5B nucleotide analog polymerase inhibitor sofosbuvir (formerly GS-7977), with or without ribavirin. With a large ...
Posted by:
gerard11
at
2013-05-03 05:00:00
on
medhelp.org
Foster City, CA -- April 8, 2013 -- Gilead Sciences (Nasdaq: GILD) today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ...
Posted by:
Willy50
at
2013-05-02 05:00:00
on
medhelp.org
... .com/stockstowatchtoday/2013/05/02/stocks-up-gilead-and-gm-rising/?mod=yahoobarrons Gilead Sciences (GILD) stock was leading the S&P 500, up more than 5%, after it announced Phase 3 trials for its hepatitis drug: Gilead Sciences today announced plans ...
Posted by:
can-do-man
at
2013-04-30 05:00:00
on
medhelp.org
... that was enough treatment for me. to influnance a decision without some science behind it would make me very uneasy. Gilead needs this info and will follow up for years to come. . I chose Gilead, they never came to my door and asked me to join a Hepititas ...
Posted by:
still_above_dirt
at
2013-04-24 05:00:00
on
medhelp.org
Genotype 1a - and I live in South Florida Enlightening if not a little alarming link Pelion to Gilead to stop using ribavirin http://www.change.org/petitions/gilead-sciences-stop-withholding-this-cure-for-hepatitis-c Link to updated trials schedule http:// ...
Posted by:
pooh55811
at
2013-04-24 05:00:00
on
medhelp.org
... from Phase 3 Studies of Gilead’s Sofosbuvir for Hepatitis C To Be Presented at 48th Annual EASL Meeting; Findings Published Online Today in The New England Journal of Medicine AMSTERDAM--(BUSINESS WIRE)--Apr. 23, 2013-- Gilead Sciences, Inc. (Nasdaq: GILD ...
Posted by:
StephenCastlecrag
at
2013-04-15 05:00:00
on
medhelp.org
... -Oral Regimen of Sofosbuvir Plus Ribavirin for Chronic Hepatitis C Patients who are Unable or Unwilling to Take Interferon Gilead Sciences today announced topline results from the Phase 3 POSITRON study examining a 12-week course of once-daily sofosbuvir ...
Posted by:
can-do-man
at
2013-04-09 05:00:00
on
medhelp.org